NYSE · AMWL

American Well Corporation

$11.05 +$0.24 (+2.22%) 1D Market open

Key Metrics

$180.62M
Market cap
P/E · TTM
$237.38M
Revenue · TTM
−$87.88M
Net income
EPS · TTM $-5.61
Dividend yield
Free cash flow −$41.85M
Beta · 1Y 1.02
EBITDA · TTM −$58.54M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    A material event was filed (Form 8-K).

    8-K - American Well Corp (0001393584) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 17
    The stock moved +20.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 17
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 13
    The stock moved +24.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$180.62M
Enterprise value
Shares outstanding16.7M
52-wk range$3.71 – $13.45
Avg volume · 20D106.3K
Net cash
Book value / share$14.51
IndustryServices-Business Services, Nec
ExchangeNYSE
About American Well Corporation
IPO dateSep 17, 2020
Employees562

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.76
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -38.9%
Net -37.0%
FCF -17.6%
ROE / ROIC -33.0% · -191.9%

Financial Health

Current ratio3.09
Quick ratio3.08
Debt / equity
Debt / EBITDA
Net cash
Working capital$175.28M

Cash Flow · TTM

Operating CF −$41.83M
Capex −$17.00K
Free cash flow −$41.85M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-7.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings